|Bid||128.09 x 1900|
|Ask||128.69 x 1900|
|Day's Range||127.93 - 128.98|
|52 Week Range||106.87 - 131.92|
|PE Ratio (TTM)||63.17|
|Expense Ratio (net)||0.06%|
For the last several quarters, Medtronic has consistently exceeded analysts’ earnings estimates.
The proton therapy market is a highly lucrative opportunity area for Varian Medical Systems (VAR). Proton therapy uses protons for treating cancer instead of X-rays. According to a Medgadget report,…
In 2Q17, Celgene’s (CELG) Otezla generated revenues of around $358 million, which reflected ~49% growth on a year-over-year basis.